MEN’S HEALTH QUARTERLY
Longevity

Sermorelin Reviews: What Users Report, What Studies Found and How to Judge Both

Most sermorelin reviews come from sellers or first-month users. The controlled studies are older, smaller and less certain than the reviews suggest.

Words by the editors ·

Sermorelin reviews are mostly written by people who sell it or who just started it, so they tell you little about whether it helps. The trial record is narrower: sermorelin raises growth hormone, and in a few small studies of a close relative in older adults some body and well-being measures moved in men, while sleep and strength results were mixed or absent.1,2 Below, what reviews can and cannot show, what the controlled studies found, and how to judge a clinic review before it shapes a decision.

In brief

  • In a placebo-controlled trial of a sermorelin-like GHRH analog in 19 people aged 55 to 71, lean mass, well-being and libido rose in men only, and sleep quality was unaffected.1
  • In 11 older men on nightly GHRH for 6 weeks, growth hormone release rose and two of six strength measures improved, but IGF-I, muscle and fat did not change.2
  • No sermorelin label appeared in a DailyMed search on November 7, 2026, and the FDA states compounded drugs are not FDA-approved.3,4
  • Reviews rarely separate sermorelin from other changes or other peptides, and larger placebo effects are linked to patient-reported outcomes.5,6

What do sermorelin reviews usually say?

The reviews that rank on search pages tend to fall into three groups: pages from clinics and compounding sellers, star ratings on provider listings, and personal accounts on forums. They commonly describe better sleep, recovery or energy over weeks, along with injection-site irritation and a complaint about monthly cost. None of these accounts has a comparison group, a blinded measurement or a lab value that a reader can check. That does not make every account false. It means the account cannot separate sermorelin from everything else that changed in the same weeks.

Three things limit what a review can tell you:

What did the controlled studies of sermorelin and similar peptides find?

Controlled data are old and small, and almost none are in healthy men seeking the benefits clinics advertise. The table sets out the studies that come closest.

StudyWho and howWhat changedWhat did not
Khorram, 1997119 people aged 55 to 71 (9 men, 10 women), single-blind placebo-controlled, 16 weeks of a GHRH analog closely related to sermorelin, injected nightlyNighttime growth hormone and IGF-I rose in both sexes. Lean body mass, insulin sensitivity, general well-being and libido rose in men only.Sleep quality was unaffected in both sexes. Blood pressure, body weight and bone density did not change.
Vittone, 1997211 healthy men aged 64 to 76 with low IGF-I, 6 weeks of nightly GHRH (1-29) injections, compared with their own baselineNighttime growth hormone release rose. Two of six strength measures and one endurance test improved.IGF-I did not rise, and weight, muscle, fat, glucose and lipids did not change.
Prakash and Goa, 19997Review of sermorelin in children with growth hormone deficiencyUseful as a diagnostic test, and growth increased in some children.Adult use is not what the review covers.

Two points follow. First, the men in these studies were 55 and older, and the Khorram trial used a modified analog, not sermorelin itself. Second, the same nightly dose strategy produced a clear rise in growth hormone in both studies, but a rise in IGF-I only in one, which is why a single glowing review says little about what a given man will experience.

Do reviews that mention better sleep match the research?

Better sleep is the benefit reviews mention most, yet it is the one the best-controlled study did not find. In the Khorram trial, sleep quality, assessed by questionnaire, was unaffected in both men and women.1 A separate experiment in healthy young women found that systemic GHRH impaired sleep.8 Neither result rules out a benefit for some people, but neither supports sleep as a reliable result. A man who reports sleeping better after starting sermorelin may be right about the change, and still be wrong about the cause.

What do reviews leave out about side effects?

Reviews tend to mention injection-site irritation and little else. The research record is similarly mild but incomplete. In children, transient facial flushing and injection-site pain were the most common events reported.7 In the 19-person Khorram trial, the only adverse effect was transient hyperlipidemia that resolved by the end of the study.1 A review of growth hormone secretagogues called them generally well tolerated, with some concern for higher blood glucose from lower insulin sensitivity, and said long-term safety data, including cancer incidence and mortality, are still needed.9 For the full breakdown, see sermorelin side effects.

Is the sermorelin in a review the same product you would get?

Often it is not, and a review rarely says. A DailyMed search on November 7, 2026 listed no sermorelin label.3 Adults who get sermorelin today receive a compounded version prepared by a pharmacy, and the FDA states that compounded drugs are not FDA-approved and have not been reviewed for safety and effectiveness.4 Strength, labeling and handling can vary by pharmacy. A 2026 endocrinology review also warned about uncertain composition and dosing in unregulated supply chains, including products sold as "research compounds".6 A glowing review of one pharmacy's product is not a review of another's.

How can you judge a sermorelin review?

A few questions sort a useful account from marketing:

  1. Does the reviewer disclose payment, an affiliate link or a financial tie to the seller?
  2. Is there a measurement, such as a lab value before and after, or only a feeling?
  3. Did anything else change, including training, sleep, weight loss or other peptides?
  4. Does the review say who prescribed it, which pharmacy compounded it and at what dose?
  5. Does it mention a downside, or are all the reports positive?

A review that fails most of these is advertising, whatever its star rating. The same standard applies to this page: it reports what the studies found, and it is not a ranking of providers. For the wider question of benefit versus evidence, see what the human studies show about sermorelin benefits, and for a decision-focused view, whether the evidence supports the claims men are sold.

What should you ask a prescriber instead of relying on reviews?

The basics of the drug are in our explainer on what sermorelin is.

Bottom line

Online sermorelin reviews are best read as stories, not evidence. The controlled record shows that sermorelin and its close relatives raise growth hormone, with mixed or absent results for sleep, strength and body composition, in small, old studies of older adults.1,2 A product that is compounded, a seller that profits and a feeling that cannot be measured are the three reasons to ask for a prescriber, a lab baseline and a review date before trusting any account, including a favorable one.

Talk to a clinician. This article explains the evidence; it cannot tell you what is right for you. A licensed clinician who knows your health history and medications can.
Important safety information. NAD+ and sermorelin are prescription injections. Compounded versions are not FDA-approved.4 Tell the prescribing clinician about every medication and supplement you take, and about any history of cancer, pituitary or thyroid conditions, or pregnancy. Only a licensed clinician who knows your health history should decide whether a prescription is appropriate for you.

Questions

Are sermorelin reviews reliable?

Mostly not. They come from sellers, affiliates or people in their first weeks, with no comparison group or lab values. Controlled studies are a better guide, though they are small and mostly in older adults.

Do reviews that mention better sleep match the research?

Not clearly. In a placebo-controlled trial of a related GHRH analog, sleep quality was unaffected in men and women, and a separate experiment in healthy young women found impaired sleep.

What side effects do sermorelin reviews miss?

Reviews mention injection-site irritation. Studies add transient flushing in children, transient hyperlipidemia in one older-adult trial and a concern about blood glucose, with long-term safety unknown.

Is the sermorelin in reviews FDA-approved?

No. A DailyMed search on November 7, 2026 listed no sermorelin label. Adults receive compounded sermorelin, which the FDA says is not FDA-approved.

What should I ask instead of relying on reviews?

Ask why the growth hormone axis is the question, which pharmacy compounds it, which labs come first, and when the plan gets reviewed or stopped.

Also in this edition

Part of our guide: Sermorelin: The Complete Guide

Notes

  1. Khorram O, Laughlin GA, Yen SS. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. J Clin Endocrinol Metab. 1997. PubMed 9141536.
  2. Vittone J, Blackman MR, Busby-Whitehead J, et al. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. 1997. PubMed 9005976.
  3. Sermorelin search. DailyMed, U.S. National Library of Medicine. Searched November 7, 2026.
  4. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
  5. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010. PubMed 20091554.
  6. Dominikowski A, et al. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol. 2026. PubMed 42395176.
  7. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999. PubMed 18031173.
  8. Mathias S, et al. Systemic growth hormone-releasing hormone (GHRH) impairs sleep in healthy young women. Psychoneuroendocrinology. 2007. PubMed 17850984.
  9. Sigalos JT, Pastuszak AW. The safety and efficacy of growth hormone secretagogues. Sex Med Rev. 2018. PubMed 28400207.